Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew L Mellor

Showing results (51-60 of 110) with videos related to

Pageof 11
Sort By:
Molecular and Cellular Biology|November 20, 2013
GCN2-dependent metabolic stress is essential for endotoxemic cytokine induction and pathologyHaiyun Liu, Lei Huang, Jillian Bradley, et al.
International Journal of Cancer|September 5, 2002
Indoleamine 2,3-dioxygenase contributes to tumor cell evasion of T cell-mediated rejectionMaria Friberg, Ronald Jennings, Marwan Alsarraj, et al.
The Journal of General Virology|April 13, 2013
Inhibition of indoleamine 2,3-dioxygenase enhances the T-cell response to influenza virus infectionJulie M Fox, Leo K Sage, Lei Huang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 1, 2019
A Validation Study on IDO Immune Biomarkers for Survival Prediction in Non-Small Cell Lung Cancer: Radiation Dose Fractionation Effect in Early-Stage DiseaseWeili Wang, Lei Huang, Jian-Yue Jin, et al.
Immunology|October 25, 2022
Characterization of age-associated B cells in early drug-naïve rheumatoid arthritis patientsGemma Vidal-Pedrola, Najib Naamane, James A Cameron, et al.
International Immunology|September 8, 2004
Specific subsets of murine dendritic cells acquire potent T cell regulatory functions following CTLA4-mediated induction of indoleamine 2,3 dioxygenaseAndrew L Mellor, Phillip Chandler, Babak Baban, et al.
Blood|April 16, 2009
Indoleamine 2,3-dioxygenase controls conversion of Foxp3+ Tregs to TH17-like cells in tumor-draining lymph nodesMadhav D Sharma, De-Yan Hou, Yanjun Liu, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 15, 2017
Soluble CD83 Inhibits T Cell Activation by Binding to the TLR4/MD-2 Complex on CD14<sup>+</sup> MonocytesJoe M Horvatinovich, Elizabeth W Grogan, Marcus Norris, et al.
Stem Cells and Development|November 6, 2009
Mouse mesenchymal stem cells suppress antigen-specific TH cell immunity independent of indoleamine 2,3-dioxygenase 1 (IDO1)Tobias V Lanz, Christiane A Opitz, Peggy P Ho, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 7, 2015
Alkylating agent melphalan augments the efficacy of adoptive immunotherapy using tumor-specific CD4+ T cellsXiaoyun Lu, Zhi-Chun Ding, Yang Cao, et al.
Pageof 11

Showing results (51-60 of 110) with videos related to

Sort By:
Pageof 11
Molecular and Cellular Biology|November 20, 2013
GCN2-dependent metabolic stress is essential for endotoxemic cytokine induction and pathologyHaiyun Liu, Lei Huang, Jillian Bradley, et al.
International Journal of Cancer|September 5, 2002
Indoleamine 2,3-dioxygenase contributes to tumor cell evasion of T cell-mediated rejectionMaria Friberg, Ronald Jennings, Marwan Alsarraj, et al.
The Journal of General Virology|April 13, 2013
Inhibition of indoleamine 2,3-dioxygenase enhances the T-cell response to influenza virus infectionJulie M Fox, Leo K Sage, Lei Huang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 1, 2019
A Validation Study on IDO Immune Biomarkers for Survival Prediction in Non-Small Cell Lung Cancer: Radiation Dose Fractionation Effect in Early-Stage DiseaseWeili Wang, Lei Huang, Jian-Yue Jin, et al.
Immunology|October 25, 2022
Characterization of age-associated B cells in early drug-naïve rheumatoid arthritis patientsGemma Vidal-Pedrola, Najib Naamane, James A Cameron, et al.
International Immunology|September 8, 2004
Specific subsets of murine dendritic cells acquire potent T cell regulatory functions following CTLA4-mediated induction of indoleamine 2,3 dioxygenaseAndrew L Mellor, Phillip Chandler, Babak Baban, et al.
Blood|April 16, 2009
Indoleamine 2,3-dioxygenase controls conversion of Foxp3+ Tregs to TH17-like cells in tumor-draining lymph nodesMadhav D Sharma, De-Yan Hou, Yanjun Liu, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 15, 2017
Soluble CD83 Inhibits T Cell Activation by Binding to the TLR4/MD-2 Complex on CD14<sup>+</sup> MonocytesJoe M Horvatinovich, Elizabeth W Grogan, Marcus Norris, et al.
Stem Cells and Development|November 6, 2009
Mouse mesenchymal stem cells suppress antigen-specific TH cell immunity independent of indoleamine 2,3-dioxygenase 1 (IDO1)Tobias V Lanz, Christiane A Opitz, Peggy P Ho, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 7, 2015
Alkylating agent melphalan augments the efficacy of adoptive immunotherapy using tumor-specific CD4+ T cellsXiaoyun Lu, Zhi-Chun Ding, Yang Cao, et al.
Pageof 11